English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Non-Alcoholic Fatty Liver Disease (NAFLD) is defined as fat accumulation above 5% of hepatocytes or liver weight in the absence of excessive alcohol intake (20-30 g/day), secondary causes (such as genetic and metabolic disorders, drug use) and any other etiology of liver disease. Although the factors affecting the formation and development of the disease are not yet clear, oxidative stress plays an important role in the pathogenesis of NAFLD. Obesity, hyperglycemia, hypertension, and dyslipidemia are among the most important risk factors for NAFLD, which is considered as the hepatic reflection of metabolic syndrome. A lifestyle change with adequate and balanced nutrition and exercise is the most effective approach in NAFLD treatment. However, the problems experienced in adapting to intensive lifestyle change in the long term have increased the interest in pharmacological approaches. Alongside particularly its powerful antioxidant effect, vitamin E, which has non-antioxidant effects such as stimulating adiponectin expression, reducing inflammatory and apoptotic responses, is considered as a potential treatment strategy for NAFLD. To determine the efficacy and safety of vitamin E, especially in the treatment of non-alcoholic steatohepatitis, randomized controlled trials are needed to obtain histological results and evaluate potential mechanisms. The aim of this review paper is to examine the efficiency of vitamin E supplementation in NAFLD treatment based on the current literature.

Non-Alkolik Yağlı Karaciğer Hastalığında Potansiyel Tedavi Yaklaşımı: E Vitamini